Ocugenix
PA - PittsburghBiotechnology
Focus: Ocugenix is a small-scale ophthalmology-focused biotechnology company based in Pittsburgh, PA with a public status but minimal disclosed commercial activity. The company operates in the specialized ophthalmology drugs segment with fewer than 50 employees.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
1-50
Open Jobs
0
About Ocugenix
AI assessmentNot HiringNo open roles listed right now. Follow Ocugenix to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
OCU-10-C-110 for Injection
Neovascular Age-related Macular Degeneration (nAMD)Clinical Trials (1)
NCT05904691Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration
Phase 1Help build intelligence for Ocugenix
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.